(R)-3-(2-((1R,4aS,5S,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)ethylidene)-4-(4-nitrophenoxy)dihydrofuran-2(3H)-one

ID: ALA5281305

Chembl Id: CHEMBL5281305

Max Phase: Preclinical

Molecular Formula: C26H33NO7

Molecular Weight: 471.55

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1CC[C@@H]2[C@@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@@H]1Oc1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C26H33NO7/c1-16-4-11-22-25(2,13-12-23(29)26(22,3)15-28)20(16)10-9-19-21(14-33-24(19)30)34-18-7-5-17(6-8-18)27(31)32/h5-9,20-23,28-29H,1,4,10-15H2,2-3H3/b19-9+/t20-,21+,22+,23-,25+,26-/m1/s1

Standard InChI Key:  YKRZOZUJNQKHNW-WIQBFJRYSA-N

Alternative Forms

  1. Parent:

    ALA5281305

    ---

Associated Targets(Human)

NR1H4 Tclin Bile acid receptor FXR (6228 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.55Molecular Weight (Monoisotopic): 471.2257AlogP: 3.96#Rotatable Bonds: 6
Polar Surface Area: 119.13Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.94CX LogD: 3.94
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.21Np Likeness Score: 1.92

References

1. Xu Y..  (2016)  Recent Progress on Bile Acid Receptor Modulators for Treatment of Metabolic Diseases.,  59  (14): [PMID:26878262] [10.1021/acs.jmedchem.5b00342]

Source